Diode Laser Spectrometer for Diagnostic Assessment of Exhaled Air Components.

The main requirements for a screening test are simplicity, non-invasiveness, safety of testing procedures, high processing speed, and ability to detect diseases at an early stage. A multichannel gas analyzer for assessment of exhaled air composition (diode laser spectrometer), non-invasive screening, and biomedical testing was developed on the basis of near-infrared diode lasers with fiber output. The device measures the following exhaled air components: CO, CO, CH, NH, HO, and HS.

[A new class of phenomena identified during the analysis of neural network of multidimensional data from patients with inflammatory lung diseases].

Aim: To apply the neural network analysis method of multi-data of patients with community-acquired pneumonia (CAP) to recognize the variability of their diagnoses and discovery of new analytical capabilities of NSA based on new methodological approaches of the meeting.

Materials And Methods: In this paper, we applied a new approach of neural network analysis of multivariate data, obtained based on clinical, laboratory and instrumental tests in 60 patients older than 65 years at various stages of the treatment of community-acquired pneumonia. Anthropometric data were used together with the results of immunological and immunochemical studies of blood serum of patients with community-acquired pneumonia who were in the acute phase of the disease.

[The protector properties of a pseudopeptide drug ingamine studied on a model of bronchospasm in guinea pigs].

The original pseudopeptide drug ingamine (4-[N-[2-(imidazol-4-yl)ethyl]-carbamoyl] butyric acid) was studied on the traditional model of antigen-induced bronchospasm in actively sensitized guinea pigs. The drug was introduced using various methods (by inhalation, via intragastric tube, and by intraperitoneal injections) in a range of doses (20, 50, 150, or 500 mg/kg). The new drug exhibited a pronounced dose-dependent protector action for all ways of introduction, but the most significant effect was observed upon inhalation, whereby the degree of bronchospasm inhibition exceeded 80%.

[The anti-inflammatory activity of intal and beta-carotene in a model of experimental granulomatous lung inflammation].

A-25 sephadex-induced granulomatous inflammation of the lungs in rats was treated with beta-carotene and intal in inhalations. Both drugs showed antiinflammatory activity reducing the area of alveolitis and emphysema in the lungs, number of neutrophils and lymphocytes in the bronchoalveolar fluid. The experimental data allow to recommend further trial of intal and beta-carotene in granulomatous pulmonary diseases.